Share Name Share Symbol Market Type Share ISIN Share Description
Emis LSE:EMIS London Ordinary Share GB00B61D1Y04 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +12.00p +1.31% 930.50p 927.50p 929.00p 931.50p 917.50p 929.50p 110,638.00 16:35:06
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Software & Computer Services 155.9 10.9 7.2 129.2 589.11

Emis (EMIS) Latest News

More Emis News
Emis Takeover Rumours

Emis (EMIS) Share Charts

1 Year Emis Chart

1 Year Emis Chart

1 Month Emis Chart

1 Month Emis Chart

Intraday Emis Chart

Intraday Emis Chart

Emis (EMIS) Discussions and Chat

Emis Forums and Chat

Date Time Title Posts
25/11/201616:57EMIS - Healthcare IT393.00

Add a New Thread

Emis (EMIS) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Emis trades in real-time

Emis (EMIS) Top Chat Posts

DateSubject
10/12/2016
08:20
Emis Daily Update: Emis is listed in the Software & Computer Services sector of the London Stock Exchange with ticker EMIS. The last closing price for Emis was 918.50p.
Emis has a 4 week average price of 884.45p and a 12 week average price of 896.92p.
The 1 year high share price is 1,176p while the 1 year low share price is currently 793p.
There are currently 63,311,396 shares in issue and the average daily traded volume is 202,692 shares. The market capitalisation of Emis is £589,112,539.78.
31/12/2015
10:28
spong_1: Rampmeister, thanks for the info!Was wondering why the share price had been so flat the last few months.I think the trading update it's early March, so will definitely get back in before then...
10/11/2015
19:57
ihatemms: Reddave- if you had waited around when they put staffline into their portfolio you would have paid an extra £2 per share (£10 to £12 within a week). You've got to get an initial holding in case the share price bolts off never to return as in the case of staff line.I bought a small amount of emis on t20 high initially but bought a lot more when it dropped back into the mid 10.50 .l then sold the initial purchase on the way back up again. That way I covered myself.
06/4/2015
22:25
strollingmolby: I see EMIS will be presenting at the next AIM Investor Focus event, on 21 April. The companies selected to present at previous events have a strong track record of dividend increases and share price growth, so the selection of EMIS could be a lead indicator of more to come after the last twelve months: HTTP://www.blackthornfocus.com/events/aim-investor-focus/april-2015 AIM Investor Focus has run since 2012. In total, 26 companies have participated at the event. Of the 26 companies that have presented, 20 have gone on to increase their dividend to shareholders at each subsequent opportunity.
12/5/2014
20:44
xjhoward: Shares mag buy recommendation:EMIS plugged into digital healthNHS software supplier poised for overdue re-ratingAnalysts see potential for 35% share price upside at healthcare software supplier EMIS (EMIS:AIM) over the next six to 12 months. They expect the company to enjoy a strong re-rating as the market properly recognises the growth potential of its digital services supplied to the NHS.The £402 million cap Leeds-based company has won favourable terms as part of the GP Systems of Choice (GPSoC) framework agreement that will see it earn more on increased usage of the EMIS Web suite and digital patient records. This win was hinted at by chief executive officer Chris Spencer in December (see Griller, Shares, 19 Dec '13).But while the market anticipates EMIS Web will fuel immediate growth, new opportunities are also emerging. The company is building momentum in the UK community pharmacies space through its Rx suite, while opportunities are seen in community health, hospital pharmacy, accident and emergency (A&E) departments and mental health.
09/5/2014
07:19
grahamg8: Mach100 being quiet may be good as it is easier to read considered comments without trawling through masses of garbage. My take on EMIS is that it has a pretty good track record. Growing revenue, operating profit, eps and dps. So this is a growth company and is currently on a P/E of 19.6, yield of 2.40% and cover of 2.125x on a share price of 666p. All well and good. To be more precise the growth in sales is 24%pa, eps 12%pa and dps 14%pa non compounded over three years. The big unknown is the investment of £57.5m in Ascribe -RNS 13/09/13. This could make or break EMIS as there is now a lot of debt on the books which is only going to be paid for if profitable sales result. If we trust the managers to continue to deliver then we invest; if the risks look too great then we sell up. Personally I'm on the fence, happy to hold at the current share price and see which way the story unfolds over the following months.
Emis share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20161210 18:32:30